Table 2.

Analysis of Patient Survival Based on Gene Expression

Probe Name	Median Survival—Low Expressed (mo)	Median Survival—High Expressed (mo)	P Value
ASXL1	14.50	20.57	0.180
BAZ1A	17.63	16.10	0.433
BAZ1B	15.67	18.90	0.513
BCL2L10	17.63	10.53	0.479
CDA	17.63	15.67	0.521
CHRAC1	15.17	18.90	0.477
CREBBP	15.17	18.90	0.608
DNMT1	16.10	23.70	0.574
DNMT3A	15.17	20.57	0.909
ERCC2	15.17	24.50	0.212
FBXO11	15.17	20.43	0.464
FLYWCH1	14.50	20.57	0.824
HELLS	17.63	14.50	0.976
IDH1	15.67	17.63	0.760
IDH2	17.63	16.10	0.624
MACROH2A1	13.67	23.70	0.120
MACROH2A2	18.90	14.50	0.330
MALSU1	12.74	13.43	0.441
MRPL4	17.63	16.10	0.513
MRPL52	15.17	20.57	0.459
MRPS26	15.16	23.70	0.601
MRTO4	20.43	11.77	0.024
NAA10	24.50	7.70	0.002
NAA15	15.17	20.57	0.422
NSUN3	10.53	24.50	0.024
POLE3	16.10	17.63	0.194
POLR1A	14.50	20.43	0.585
POLR1B	17.63	11.77	0.164
POLR1C	18.90	16.10	0.377
POLR1E	20.43	14.50	0.03
POLR3D	15.17	20.57	0.729
POLR3H	17.63	16.10	0.880
PWWP2B	15.17	20.43	0.782
RING1	14.50	24.50	0.076
RIOX2	15.17	23.70	0.577
RRM1	20.57	10.53	0.425
RRM2	23.70	10.53	0.231
RRP1	15.67	20.57	0.835
RRP9	17.63	16.10	0.315
SLC28A3	23.70	11.77	0.102
SLC29A1	18.90	15.67	0.926
SMARCA5	15.17	23.70	0.647
TET2	14.50	20.43	0.308
TP53	14.50	24.50	0.308
UCK1	15.17	20.43	0.381
UCK2	18.90	16.10	0.241
EP300	15.67	18.90	0.671